• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 5 - Elucidating the Economic Burden of MS

Video

Multiple sclerosis (MS) manifests in various subtypes, with the bulk of disability occurring among individuals with progressive disease. According to Dr. Fred Lublin, the primary drivers of burden in MS are motor dysfunction and cerebellar dysfunction, and there are numerous facets that account for the growing burden of the neurological condition. Dr. Gary Owens noted that the economic burden of MS can really be categorized into 3 phases: Phase 1 is the cost burden associated with initial presentation and the ensuing, intense diagnostic evaluation period; Phase 2 is comprised of diagnosed patients receiving disease-modifying treatments; and Phase 3 consists of patients with progressive disease and the expenditures associated with chronic care.


Related Videos
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
dr krystyn van vliet
Patrick Vermersch, MD, PhD
dr xavier montalban
ateyeh soroush
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Mila Felder, MD, FACEP
James Robinson, PhD, MPH, University of California, Berkeley
Patrick Vermersch, MD, PhD
James Robinson, PhD, MPH, University of California, Berkeley
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.